BORN TO DISCOVER
30+ YEAR HISTORY
We are the only biopharmaceutical company led by physician-scientists for our entire, 30+ year history. From our first days, science was and remains our central guiding principle. We continue to invest in groundbreaking technologies and research, and employ strategies that enable our scientists to consistently explore new paths.Read a profile of Regeneron Scientist Aynur Hermann Read a profile of Regeneron Scientist Xiaobin Xu
We are focused on addressing a broad range of serious medical conditions including ophthalmology, cancer, rheumatoid arthritis, asthma, atopic dermatitis, pain and infectious diseases. Our industry-leading research and development engine enables us to develop all potential drug candidates from within our own labs.Our science
Our strategy is to follow the science, rather than limiting our innovations to any one therapeutic area. We are focused on solving the human body's most complex mysteries — from ophthalmology to cancer to inflammation to pain to cardiovascular disease. This includes 20 product candidates in clinical development across multiple therapeutic areas.Our pipeline
TECHNOLOGY THAT BREAKS BOTTLENECKS
Our core capabilities for target discovery and validation are enabled by a series of Regeneron-invented technologies that accelerate, improve and disrupt the traditional drug discovery and development process. Collectively, these technologies represent some of the most valuable biotechnologies ever created, and aid our efforts to continuously accelerate the average timeline from discovery to drug approval.See how we're raising the bar
FIND OUT WHY OUR SCIENTISTS DO WHAT THEY DO
Our colleagues have backgrounds as diverse as the problems we’re working to solve. Here are just a few of their stories.
The musical theater stage and the Regeneron lab have more in common than you might think. Both inspire a group of people to work together toward a common goal. Every day, Regeneron scientist Alyson works with her ophthalmology team to help answer the important questions about retinal eye diseases to ensure patients are receiving the most effective treatments.
Dinko’s curiosity about the natural world inspired him to pursue a career in science. Now he uses imaging technology to innovate and positively impact the lives of patients with rare diseases like Fibrodysplasia Ossificans Progressiva (FOP).
Our President and Chief Scientist, George Yancopoulos, followed in the footsteps of his grandfather to pursue science. Watch to find out how he works every day to invent and discover the next new medicine that makes a difference in patients’ lives.
Biology is a complex puzzle, and scientists, like Jean, work to solve these puzzles by gathering and interpreting results that inform the creation of life-changing medicines. Jean shares how her passion for designing dresses led her to a career designing experiments at Regeneron.
When she was young, Petra wanted to be a veterinarian like her dad. But then she enjoyed working with people. Now, she is a Regeneron scientist finding ways to outsmart cancer with immuno-oncology.
Regeneron scientist Vishal followed his curiosity to a career studying antibodies to help bring medicine to people living with disease.
Clinical trials are crucial to determine if compounds are useful, effective and safe. Wilson oversees this process at Regeneron to ensure our clinical plans are executed in high quality.
Zack’s curiosity about the science behind our life-changing medicines led him to a career on our Industrial Operations and Product Supply (IOPS) team. His work is the scientific backbone of our product supply facility.
UNITED IN DISCOVERY
Along with our distinguished collaborators, we are uncovering cutting-edge scientific advances. Partner with our researchers and help turn science into life-changing medicine.Our collaborations